Liquidia Corp logo

Liquidia Corp

$ 7.43 -0.275 (-3.57%) 03:53 PM EST
P/E:
At Loss
P/B:
4.54
Market Cap:
$ 461.12M
Enterprise V:
$ 413.06M
Volume:
934.12K
Avg Vol (2M):
2.26M
Also Trade In:
Volume:
934.12K
Market Cap $:
461.12M
PE Ratio:
At Loss
Avg Vol (2-Month):
2.26M
Enterprise Value $:
413.06M
PB Ratio:
4.54
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Liquidia Corp
NAICS : 325414 SIC : 2836
419 Davis Drive, Suite 100, Morrisville, NC, USA, 27560
Description
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH). It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles designed to improve the safety, efficacy, and performance of a wide range of therapies. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension.
Name Current Vs Industry Vs History
Cash-To-Debt 4.2
Equity-to-Asset 0.73
Debt-to-Equity 0.24
Debt-to-EBITDA -0.64
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 4.11
Distress
Grey
Safe
Beneish M-Score -2.44
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 69.22
9-Day RSI 70.52
14-Day RSI 69.55
6-1 Month Momentum % -33.03
12-1 Month Momentum % 51.63

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 15.87
Quick Ratio 15.87
Cash Ratio 15.19
Days Sales Outstanding 84.99
Days Payable 199.34

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -49.9

Financials (Next Earnings Date:2022-11-03 Est.)

LQDA's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:LQDA

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 13.804
EPS (TTM) ($) -0.82
Beta 0.39
Volatility % 59.52
14-Day RSI 69.55
14-Day ATR ($) 0.719582
20-Day SMA ($) 5.84375
12-1 Month Momentum % 51.63
52-Week Range ($) 2.4 - 8.7899
Shares Outstanding (Mil) 64.36

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Liquidia Corp Filings

Document Form Filing Date
No Filing Data

Headlines

See More